Page 17 - Peter Bach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

With little science to guide them, experts clash on best use of limited supply

Tobias Schwarz/AFP via Getty Images This story is part of a group of stories called Finding the best ways to do good. In the past couple of weeks, experts and pundits have debated a big question surrounding the rollout of the Covid-19 vaccines from Pfizer/BioNTech and Moderna: Do we stick to two doses for every person, spaced a couple of weeks apart, as originally planned? Or should we go ahead and give out single doses to more people even when we’re not sure we’ll manage the second dose as planned — to get a shot in as many arms as possible, even if there’s less certainty a...

Biden says he’ll tell the U.S. to stop holding back doses of the Covid-19 vaccine. The debate about holding back doses, explained. Vox.com 1/8/2021 Kelsey Piper © Tobias Schwarz/AFP via Getty Images In Berlin, people line up to get vaccinated against Covid-19. In the past couple of weeks, experts and pundits have debated a big question surrounding the rollout of the Covid-19 vaccines from Pfizer/BioNTech and Moderna: Do we stick to two doses for every person, spaced a couple of weeks apart, as was originally planned? Or should we go ahead and give out single doses to mo...

A If there’s a common theme in the errors of the US response to Covid-19, it’s been the astounding amount of squandering. Our leaders squandered time, as well as public trust and people’s economic and emotional resources. And they squandered the chance to do good science — testing drugs and vaccines in a way that serves the public interest rather than the interest of pharmaceutical companies. There’s no question that Covid-19 vaccines and therapies will save many lives. But we’re not doing the kinds of scientific studies needed to determine the best vaccines and therapies to ...

The thing that's wrong with the COVID-19 vaccine trials We're not doing the kinds of scientific studies needed to get the most out of this work.  By Faye Flam, Bloomberg Opinion (TNS) December 22, 2020 — 11:22am Text size Copy shortlink: If there's a common theme in the errors of the U.S. response to COVID-19, it's been the astounding amount of squandering. Our leaders squandered time, as well as public trust and people's economic and emotional resources. And they squandered the chance to do good science — testing drugs and vac...